Teradyne (TER) Financials

$357.10 +19.66 (+5.83%)

Closing price 04:00 PM Eastern

Extended Trading

$361.14 +4.03 (+1.13%)

As of 07:59 PM Eastern

Annual Income Statements for Teradyne

This table shows Teradyne's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	206	-43	258	452	467	784	1,015	716	449	542	554
Consolidated Net Income / (Loss)	206	-43	258	452	467	784	1,015	716	449	542	554
Net Income / (Loss) Continuing Operations	206	-43	258	452	467	784	1,015	716	449	542	554
Total Pre-Tax Income	253	-55	524	468	526	901	1,161	840	526	609	653
Total Operating Income	243	-63	525	474	554	928	1,201	832	501	594	650
Total Gross Profit	916	959	1,221	1,220	1,340	1,786	2,207	1,867	1,537	1,649	1,857
Total Revenue	1,640	1,753	2,137	2,101	2,295	3,121	3,703	3,155	2,676	2,820	3,190
Operating Revenue	1,640	1,753	2,137	2,101	2,295	3,121	3,703	3,155	2,676	2,820	3,190
Total Cost of Revenue	724	795	915	880	955	1,336	1,496	1,288	1,140	1,171	1,333
Operating Cost of Revenue	724	795	915	880	955	1,336	1,496	1,288	1,140	1,171	1,333
Total Operating Expenses	673	1,022	696	747	786	857	1,006	1,035	1,036	1,055	1,207
Selling, General & Admin Expense	306	317	349	391	437	465	548	558	577	617	649
Research & Development Expense	292	292	307	302	323	375	428	441	418	461	505
Amortization Expense	69	53	31	39	40	31	21	19	19	19	15
Other Operating Expenses / (Income)	-	-	-	-	-	-	-	0.00	0.00	-57	0.00
Restructuring Charge	5.08	22	9.36	15	-14	-13	9.31	17	21	16	39
Total Other Income / (Expense), net	10	7.91	-0.93	-6.00	-28	-27	-40	8.45	25	15	3.21
Interest Expense	1.88	3.64	22	22	22	24	18	3.72	3.81	3.59	6.85
Interest & Investment Income	7.21	9.30	18	20	17	5.98	2.63	6.38	27	25	16
Other Income / (Expense), net	4.82	2.25	2.93	-4.67	-23	-9.19	-25	5.79	0.96	-5.89	-5.64
Income Tax Expense	47	-12	267	16	58	117	146	125	77	60	79
Other Gains / (Losses), net	-	-	-	-	-	-	-	0.00	0.00	-7.21	-20
Basic Earnings per Share	$0.98	($0.21)	$1.30	$2.41	$2.74	$4.72	$6.15	$4.52	$2.91	$3.41	$3.48
Weighted Average Basic Shares Outstanding	211.54M	202.58M	198.07M	187.67M	170.43M	166.12M	164.96M	158.43M	154.31M	159.08M	159.12M
Diluted Earnings per Share	$0.97	($0.21)	$1.28	$2.35	$2.60	$4.28	$5.53	$4.22	$2.73	$3.32	$3.47
Weighted Average Diluted Shares Outstanding	213.32M	202.58M	201.64M	192.61M	179.46M	183.04M	183.63M	169.73M	164.30M	163.31M	159.72M
Weighted Average Basic & Diluted Shares Outstanding	210.70M	206.80M	198.20M	173.63M	166.78M	166.69M	162.42M	156.05M	153.08M	161.72M	156.56M
Cash Dividends to Common per Share	$0.24	$0.24	$0.28	$0.36	$0.09	$0.10	$0.40	$0.44	$0.44	$0.48	$0.48

This table shows Teradyne's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	12/31/2025	3/29/2026
Net Income / (Loss) Attributable to Common Shareholders	128	117	64	186	146	146	99	78	120	257	399
Consolidated Net Income / (Loss)	128	117	64	186	146	146	99	78	120	257	399
Net Income / (Loss) Continuing Operations	128	117	64	186	146	146	99	78	120	257	399
Total Pre-Tax Income	144	140	73	219	159	158	119	97	148	290	466
Total Operating Income	144	124	78	210	152	154	121	91	145	293	473
Total Gross Profit	398	380	339	426	437	447	415	373	449	620	781
Total Revenue	704	671	600	730	737	753	686	652	769	1,083	1,282
Operating Revenue	704	671	600	730	737	753	686	652	769	1,083	1,282
Total Cost of Revenue	305	291	261	304	301	306	270	279	320	464	502
Operating Cost of Revenue	305	291	261	304	301	306	270	279	320	464	502
Total Operating Expenses	254	255	262	215	284	294	295	282	304	326	308
Selling, General & Admin Expense	138	142	149	154	158	156	157	158	169	165	167
Research & Development Expense	104	102	103	112	117	128	118	118	125	143	136
Amortization Expense	4.72	4.65	4.70	4.66	4.75	4.66	4.57	3.73	3.51	3.45	2.22
Other Operating Expenses / (Income)	0.00	-	-	-57	0.00	-	0.00	0.00	0.00	-	0.00
Restructuring Charge	6.86	6.03	4.43	2.01	4.58	4.55	15	2.37	6.59	15	3.43
Total Other Income / (Expense), net	0.31	15	-4.87	9.04	6.92	4.21	-1.78	5.82	2.80	-3.63	-7.33
Interest Expense	0.96	0.81	0.66	1.53	0.81	0.59	0.80	0.81	1.31	3.94	3.15
Interest & Investment Income	6.87	8.86	7.87	6.72	5.08	5.11	5.08	4.35	3.19	3.08	2.42
Other Income / (Expense), net	-5.60	7.43	-12	3.85	2.65	-0.31	-6.06	2.27	0.92	-2.77	-6.60
Income Tax Expense	16	23	8.71	33	12	5.41	15	12	23	29	62
Other Gains / (Losses), net	0.00	-	0.00	0.00	-1.08	-	-5.58	-5.93	-5.20	-3.21	-4.61
Basic Earnings per Share	$0.83	$0.76	$0.42	$1.18	$0.89	$0.92	$0.61	$0.49	$0.75	$1.63	$2.55
Weighted Average Basic Shares Outstanding	153.76M	154.31M	153.05M	157.80M	163.00M	159.08M	161.50M	159.97M	158.60M	159.12M	156.41M
Diluted Earnings per Share	$0.78	$0.72	$0.40	$1.14	$0.89	$0.89	$0.61	$0.49	$0.75	$1.62	$2.53
Weighted Average Diluted Shares Outstanding	164.05M	164.30M	162.35M	163.47M	164.25M	163.31M	162.00M	160.14M	159.10M	159.72M	157.64M
Weighted Average Basic & Diluted Shares Outstanding	152.88M	153.08M	156.11M	163.18M	162.86M	161.72M	160.42M	159.07M	156.61M	156.56M	156.54M
Cash Dividends to Common per Share	$0.11	-	$0.12	$0.12	-	-	$0.12	$0.12	-	-	$0.13

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-30	43	122	497	-153	140	208	-267	-97	-204	-260
Net Cash From Operating Activities	423	455	626	477	579	869	1,098	578	585	672	674
Net Cash From Continuing Operating Activities	423	455	626	477	579	869	1,098	578	585	672	674
Net Income / (Loss) Continuing Operations	206	-43	258	452	467	784	1,015	716	449	542	554
Consolidated Net Income / (Loss)	206	-43	258	452	467	784	1,015	716	449	542	554
Depreciation Expense	68	65	66	67	71	80	91	91	92	101	111
Amortization Expense	90	52	35	42	50	57	34	-5.67	19	19	17
Non-Cash Adjustments To Reconcile Net Income	43	380	39	49	71	56	82	89	73	33	117
Changes in Operating Assets and Liabilities, net	15	1.93	228	-134	-80	-108	-123	-311	-47	-22	-125
Net Cash From Investing Activities	-114	-640	-263	923	-157	-570	120	44	-180	-622	-369
Net Cash From Continuing Investing Activities	-114	-640	-263	923	-157	-570	120	44	-180	-622	-369
Purchase of Property, Plant & Equipment	-90	-85	-105	-114	-135	-185	-132	-163	-160	-730	-250
Acquisitions	-283	-	-	-169	-80	0.15	-12	-	0.00	0.00	-144
Purchase of Investments	-1,424	-1,656	-1,392	-919	-663	-900	-662	-287	-162	-46	-33
Divestitures	-	-	-	-	-	-	-	0.00	0.00	90	0.00
Sale and/or Maturity of Investments	1,676	1,096	1,229	2,117	718	515	927	491	146	62	58
Other Investing Activities, net	6.50	5.05	5.06	9.05	2.91	0.55	0.00	0.00	-4.54	0.87	0.00
Net Cash From Financing Activities	-339	228	-245	-903	-574	-158	-1,009	-893	-502	-252	-562
Net Cash From Continuing Financing Activities	-339	228	-245	-903	-574	-158	-1,009	-893	-502	-252	-562
Repayment of Debt	-2.25	-	-	-	0.00	0.00	-343	-67	-50	-185	-50
Repurchase of Common Equity	-300	-146	-200	-823	-500	-88	-600	-752	-397	-199	-702
Payment of Dividends	-51	-49	-55	-67	-61	-66	-66	-70	-68	-76	-76
Issuance of Debt	-	451	-	-	-	-	-	0.00	0.00	185	250
Issuance of Common Equity	20	88	24	21	29	29	33	29	34	37	32
Other Financing Activities, net	-5.52	-116	-14	-34	-42	-32	-32	-33	-21	-14	-16
Effect of Exchange Rate Changes	-	-	3.45	0.44	-0.57	-	-2.07	-	-0.88	-2.28	-3.15
Cash Interest Paid	0.30	0.45	6.45	6.21	6.00	6.44	4.24	1.50	0.30	0.77	3.16

This table details how cash moves in and out of Teradyne's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	12/31/2025	3/29/2026
Net Change in Cash & Equivalents	24	121	-50	-285	88	43	-78	-136	-67	21	-52
Net Cash From Operating Activities	174	249	7.28	216	166	283	162	182	49	282	265
Net Cash From Continuing Operating Activities	174	249	7.28	216	166	283	162	182	49	282	265
Net Income / (Loss) Continuing Operations	128	117	64	186	146	146	99	78	120	257	399
Consolidated Net Income / (Loss)	128	117	64	186	146	146	99	78	120	257	399
Depreciation Expense	24	23	23	26	26	26	26	27	27	32	30
Amortization Expense	4.50	4.69	4.77	4.38	4.99	0.28	4.78	4.08	3.87	3.81	2.42
Non-Cash Adjustments To Reconcile Net Income	26	7.74	33	-36	9.98	30	33	26	23	36	37
Changes in Operating Assets and Liabilities, net	-8.08	96	-118	36	-20	80	-0.15	47	-124	-47	-203
Net Cash From Investing Activities	-28	-30	-24	-481	-50	-67	-62	-178	-67	-61	-67
Net Cash From Continuing Investing Activities	-28	-30	-24	-481	-50	-67	-62	-178	-67	-61	-67
Purchase of Property, Plant & Equipment	-35	-44	-44	-569	-54	-62	-67	-53	-67	-63	-65
Acquisitions	-	-	0.00	-	-	-	-17	-127	-	-	0.00
Purchase of Investments	-39	-24	-16	-12	-7.34	-11	-11	-6.40	-10	-5.53	-41
Divestitures	-	-	-	-	3.18	-	0.00	-	-	-	0.00
Sale and/or Maturity of Investments	51	38	35	13	8.62	5.63	33	8.08	9.70	7.50	38
Other Investing Activities, net	-5.00	-	0.87	-	-	-	0.00	-	-	-	0.00
Net Cash From Financing Activities	-128	-91	-37	-23	-29	-163	-177	-137	-48	-201	-250
Net Cash From Continuing Financing Activities	-128	-91	-37	-23	-29	-163	-177	-137	-48	-201	-250
Repayment of Debt	-9.28	-24	0.00	-185	-	-	0.00	-	-	-50	-250
Repurchase of Common Equity	-119	-51	-22	-8.19	-25	-144	-157	-117	-244	-183	-5.52
Payment of Dividends	-17	-17	-18	-19	-20	-19	-19	-19	-19	-19	-20
Issuance of Debt	-	-	-	-	-	-	0.00	-	200	50	50
Issuance of Common Equity	17	0.18	17	4.90	15	0.07	15	-	15	1.78	15
Other Financing Activities, net	-0.28	-0.20	-13	-0.32	-0.40	-0.27	-15	-0.23	-0.30	-0.45	-39
Effect of Exchange Rate Changes	-	-6.65	3.24	-	-	-	-0.77	-3.20	-0.36	1.18	0.58

This table presents Teradyne's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	2,549	2,762	3,110	2,707	2,787	3,652	3,809	3,501	3,487	3,709	4,184
Total Current Assets	1,260	1,624	2,270	1,732	1,659	2,415	2,576	2,258	2,162	1,816	1,949
Cash & Equivalents	265	308	430	927	774	914	1,122	855	758	553	294
Short-Term Investments	478	871	1,348	190	137	522	244	40	62	46	28
Accounts Receivable	211	192	273	291	362	498	551	491	422	471	787
Inventories, net	154	136	108	154	197	222	243	325	310	298	380
Prepaid Expenses	92	116	112	171	189	250	406	533	549	429	428
Other Current Assets	6.19	-	-	-	-	9.25	9.45	14	38	18	33
Other Current Nonoperating Assets	-	-	-	-	-	-	-	0.00	23	0.00	0.00
Plant, Property, & Equipment, net	273	254	268	280	320	395	387	419	445	508	563
Total Noncurrent Assets	1,015	885	571	694	808	842	846	825	879	1,384	1,671
Long-Term Investments	266	434	126	88	104	118	134	111	117	619	663
Goodwill	488	223	252	382	416	454	426	403	416	395	521
Intangible Assets	240	100	79	125	125	101	76	53	35	16	51
Noncurrent Deferred & Refundable Income Taxes	7.40	107	84	71	75	88	102	143	176	222	275
Employee Benefit Assets	0.64	7.71	17	17	18	17	15	12	12	12	12
Other Noncurrent Operating Assets	13	12	12	12	68	64	93	103	112	120	148
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	0.00	12	-	0.00
Total Liabilities & Shareholders' Equity	2,549	2,762	3,110	2,707	2,787	3,652	3,809	3,501	3,487	3,709	4,184
Total Liabilities	583	934	1,156	1,184	1,307	1,442	1,245	1,050	961	889	1,388
Total Current Liabilities	373	373	454	476	539	701	805	746	660	625	1,115
Short-Term Debt	16	1.05	24	35	9.11	33	19	50	-	0.00	200
Accounts Payable	92	95	86	101	127	134	153	140	180	135	269
Accrued Expenses	44	51	59	78	71	78	124	112	115	91	112
Current Deferred Revenue	86	84	84	78	105	135	146	148	100	108	153
Current Deferred & Payable Income Tax Liabilities	22	30	59	36	44	81	89	65	49	68	107
Current Employee Benefit Liabilities	114	110	142	149	164	220	254	212	192	205	255
Other Current Liabilities	-	-	-	-	19	21	20	19	18	19	19
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	0.00	7.38	0.00	0.00
Total Noncurrent Liabilities	210	561	702	708	768	741	440	304	301	265	273
Noncurrent Deferred Revenue	26	23	178	117	129	133	122	104	82	65	51
Noncurrent Deferred & Payable Income Tax Liabilities	27	12	6.72	21	14	11	6.33	3.27	0.18	1.04	5.38
Noncurrent Employee Benefit Liabilities	104	107	120	117	134	151	151	116	132	133	145
Other Noncurrent Operating Liabilities	54	66	31	73	96	69	72	80	85	65	72
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	0.00	2.00	0.00	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,966	1,829	1,954	1,522	1,480	2,207	2,562	2,451	2,526	2,819	2,796
Total Preferred & Common Equity	1,966	1,829	1,954	1,522	1,480	2,207	2,562	2,451	2,526	2,819	2,796
Total Common Equity	1,966	1,829	1,954	1,522	1,480	2,207	2,562	2,451	2,526	2,819	2,796
Common Stock	1,506	1,619	1,663	1,694	1,741	1,786	1,832	1,775	1,846	1,930	2,009
Retained Earnings	468	230	272	-158	-242	387	737	726	707	971	744
Accumulated Other Comprehensive Income / (Loss)	-8.14	-20	19	-13	-19	34	-5.95	-50	-27	-81	42

This table presents Teradyne's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	7/2/2023	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	3/29/2026
Total Assets	3,395	3,371	3,487	3,411	3,632	3,770	3,709	3,706	3,762	3,964	4,434
Total Current Assets	2,124	2,099	2,162	2,065	1,756	1,839	1,816	1,756	1,584	1,750	2,173
Cash & Equivalents	613	637	758	707	422	510	553	476	339	273	242
Short-Term Investments	95	80	62	41	39	42	46	32	29	25	3.65
Accounts Receivable	493	456	422	426	470	484	471	460	433	594	1,108
Inventories, net	347	323	310	314	289	297	298	345	351	367	363
Prepaid Expenses	561	593	549	538	516	490	429	424	413	469	439
Other Current Assets	14	11	38	16	21	16	18	19	19	23	19
Other Current Nonoperating Assets	-	-	23	22	0.00	0.00	0.00	-	0.00	0.00	0.00
Plant, Property, & Equipment, net	437	436	445	457	472	492	508	542	560	570	586
Total Noncurrent Assets	834	835	879	888	1,403	1,439	1,384	1,409	1,618	1,644	1,675
Long-Term Investments	105	104	117	122	648	664	619	623	666	668	671
Goodwill	412	401	416	408	405	419	395	409	520	520	514
Intangible Assets	45	39	35	30	25	21	16	18	58	55	49
Noncurrent Deferred & Refundable Income Taxes	152	163	176	186	193	202	222	231	240	253	282
Employee Benefit Assets	12	11	12	11	11	13	12	12	12	13	12
Other Noncurrent Operating Assets	109	117	112	120	120	119	120	115	122	136	147
Other Noncurrent Nonoperating Assets	-	-	12	11	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	3,395	3,371	3,487	3,411	3,632	3,770	3,709	3,706	3,762	3,964	4,434
Total Liabilities	960	929	961	853	901	867	889	908	925	1,246	1,290
Total Current Liabilities	670	641	660	554	626	595	625	649	675	995	1,012
Short-Term Debt	33	24	-	-	-	-	-	-	-	200	0.00
Accounts Payable	153	176	180	154	161	158	135	187	172	228	345
Accrued Expenses	114	123	115	101	109	105	91	100	110	139	123
Current Deferred Revenue	120	109	100	100	103	100	108	120	124	133	197
Current Deferred & Payable Income Tax Liabilities	65	36	49	56	74	53	68	81	73	72	173
Current Employee Benefit Liabilities	164	155	192	121	161	160	205	143	176	204	156
Other Current Liabilities	20	18	18	17	18	19	19	18	20	19	18
Other Current Nonoperating Liabilities	-	-	7.38	4.69	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Noncurrent Liabilities	290	289	301	299	275	272	265	259	249	251	278
Noncurrent Deferred Revenue	83	79	82	79	61	66	65	64	40	44	58
Noncurrent Deferred & Payable Income Tax Liabilities	1.30	0.24	0.18	0.13	0.10	0.16	1.04	0.87	6.76	6.89	4.56
Noncurrent Employee Benefit Liabilities	124	123	132	135	135	138	133	136	139	143	143
Other Noncurrent Operating Liabilities	82	86	85	82	79	69	65	58	63	58	72
Other Noncurrent Nonoperating Liabilities	-	-	2.00	1.94	0.00	0.00	0.00	-	0.00	0.00	0.00
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,435	2,441	2,526	2,558	2,731	2,903	2,819	2,797	2,837	2,717	3,144
Total Preferred & Common Equity	2,435	2,441	2,526	2,558	2,731	2,903	2,819	2,797	2,837	2,717	3,144
Total Common Equity	2,435	2,441	2,526	2,558	2,731	2,903	2,819	2,797	2,837	2,717	3,144
Common Stock	1,804	1,835	1,846	1,867	1,886	1,917	1,930	1,946	1,961	1,993	2,006
Retained Earnings	661	654	707	730	889	990	971	893	835	687	1,118
Accumulated Other Comprehensive Income / (Loss)	-30	-48	-27	-40	-44	-4.03	-81	-42	41	37	20

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.50%	6.93%	21.87%	-1.68%	9.24%	36.01%	18.63%	-14.79%	-15.17%	5.36%	13.13%
EBITDA Growth	37.65%	-86.20%	1,022.76%	-8.05%	12.54%	62.08%	23.23%	-29.10%	-33.58%	14.74%	9.15%
EBIT Growth	157.97%	-124.50%	970.02%	-11.20%	13.19%	73.11%	27.95%	-28.77%	-40.07%	17.10%	9.61%
NOPAT Growth	141.22%	-122.24%	685.65%	77.25%	7.58%	64.14%	29.87%	-32.50%	-39.60%	25.23%	6.60%
Net Income Growth	154.06%	-121.03%	693.47%	75.32%	3.47%	67.74%	29.39%	-29.48%	-37.28%	20.86%	2.15%
EPS Growth	162.16%	-121.65%	709.52%	83.59%	10.64%	64.62%	29.21%	-23.69%	-35.31%	21.61%	4.52%
Operating Cash Flow Growth	-14.02%	7.59%	37.63%	-23.88%	21.36%	50.14%	26.40%	-47.38%	1.26%	14.86%	0.33%
Free Cash Flow Firm Growth	-97.70%	5,621.09%	7.83%	-57.32%	115.72%	70.95%	54.80%	-59.30%	-6.10%	38.08%	-67.53%
Invested Capital Growth	24.57%	-41.45%	-22.69%	66.36%	18.51%	22.84%	9.90%	27.66%	4.48%	2.41%	25.57%
Revenue Q/Q Growth	-0.29%	3.64%	4.88%	1.95%	6.25%	3.46%	3.52%	-4.63%	-2.24%	3.01%	11.56%
EBITDA Q/Q Growth	26.92%	193.57%	6.55%	3.48%	7.26%	8.78%	1.52%	-9.13%	-9.04%	2.98%	23.34%
EBIT Q/Q Growth	88.77%	52.65%	8.10%	3.30%	7.96%	9.19%	2.49%	-7.12%	-10.85%	3.80%	27.04%
NOPAT Q/Q Growth	107.95%	51.16%	-40.17%	125.75%	-0.03%	8.23%	1.85%	-9.83%	-9.23%	9.09%	25.24%
Net Income Q/Q Growth	99.87%	60.67%	-40.07%	123.58%	-3.85%	10.00%	2.81%	-6.74%	-10.96%	5.69%	25.04%
EPS Q/Q Growth	97.96%	61.82%	-40.47%	123.81%	-3.35%	9.46%	4.14%	-5.17%	-10.49%	5.40%	26.64%
Operating Cash Flow Q/Q Growth	-22.73%	-2.83%	21.35%	8.88%	5.46%	5.35%	6.90%	-20.37%	12.58%	5.29%	-0.14%
Free Cash Flow Firm Q/Q Growth	-95.36%	2.88%	23.13%	77.30%	-12.56%	15.50%	10.65%	-34.84%	39.42%	10.95%	-15.19%
Invested Capital Q/Q Growth	0.47%	7.68%	-31.81%	-3.00%	3.38%	0.76%	-5.16%	4.50%	-4.93%	-5.07%	3.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.85%	54.68%	57.17%	58.09%	58.38%	57.21%	59.59%	59.18%	57.42%	58.48%	58.22%
EBITDA Margin	24.78%	3.20%	29.47%	27.56%	28.40%	33.84%	35.15%	29.25%	22.90%	24.94%	24.21%
Operating Margin	14.82%	-3.59%	24.59%	22.55%	24.12%	29.74%	32.43%	26.37%	18.72%	21.06%	20.38%
EBIT Margin	15.11%	-3.46%	24.72%	22.33%	23.14%	29.45%	31.76%	26.55%	18.76%	20.85%	20.20%
Profit (Net Income) Margin	12.59%	-2.48%	12.06%	21.51%	20.37%	25.12%	27.40%	22.68%	16.77%	19.23%	17.37%
Tax Burden Percent	81.57%	78.86%	49.14%	96.58%	88.91%	87.03%	87.39%	85.14%	85.38%	89.05%	84.81%
Interest Burden Percent	102.15%	90.68%	99.27%	99.72%	99.01%	98.02%	98.71%	100.32%	104.69%	103.60%	101.37%
Effective Tax Rate	18.43%	0.00%	50.86%	3.43%	11.09%	12.97%	12.61%	14.86%	14.62%	9.77%	12.14%
Return on Invested Capital (ROIC)	22.60%	-5.72%	51.12%	78.02%	61.50%	83.52%	93.75%	53.09%	27.97%	33.86%	31.63%
ROIC Less NNEP Spread (ROIC-NNEP)	21.88%	-5.77%	51.15%	78.52%	65.04%	86.24%	96.49%	52.48%	25.78%	33.26%	33.34%
Return on Net Nonoperating Assets (RNNOA)	-12.39%	3.43%	-37.49%	-52.02%	-30.36%	-41.03%	-51.25%	-24.56%	-9.93%	-13.57%	-11.90%
Return on Equity (ROE)	10.21%	-2.29%	13.63%	25.99%	31.14%	42.49%	42.50%	28.53%	18.03%	20.29%	19.73%
Cash Return on Invested Capital (CROIC)	0.72%	46.58%	76.71%	28.19%	44.56%	63.02%	84.32%	28.79%	23.58%	31.48%	8.96%
Operating Return on Assets (OROA)	9.74%	-2.29%	17.99%	16.13%	19.33%	28.55%	31.52%	22.92%	14.37%	16.34%	16.33%
Return on Assets (ROA)	8.12%	-1.64%	8.78%	15.54%	17.02%	24.35%	27.19%	19.57%	12.84%	15.08%	14.04%
Return on Common Equity (ROCE)	10.21%	-2.29%	13.63%	25.99%	31.14%	42.45%	42.45%	28.52%	18.03%	20.29%	19.73%
Return on Equity Simple (ROE_SIMPLE)	10.50%	-2.37%	13.19%	29.68%	31.58%	35.53%	39.59%	29.19%	17.77%	19.24%	0.00%
Net Operating Profit after Tax (NOPAT)	198	-44	258	458	492	808	1,049	708	428	536	571
NOPAT Margin	12.09%	-2.51%	12.08%	21.78%	21.45%	25.88%	28.34%	22.45%	15.99%	19.00%	17.90%
Net Nonoperating Expense Percent (NNEP)	0.72%	0.06%	-0.03%	-0.50%	-3.54%	-2.71%	-2.74%	0.61%	2.18%	0.60%	-1.71%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	28.32%	16.94%	19.00%	19.07%
Cost of Revenue to Revenue	44.15%	45.32%	42.83%	41.91%	41.62%	42.79%	40.41%	40.82%	42.58%	41.52%	41.78%
SG&A Expenses to Revenue	18.68%	18.05%	16.33%	18.60%	19.05%	14.89%	14.79%	17.69%	21.57%	21.88%	20.34%
R&D to Revenue	17.82%	16.66%	14.38%	14.35%	14.07%	12.01%	11.55%	13.96%	15.62%	16.34%	15.82%
Operating Expenses to Revenue	41.03%	58.27%	32.58%	35.54%	34.26%	27.47%	27.17%	32.81%	38.70%	37.42%	37.85%
Earnings before Interest and Taxes (EBIT)	248	-61	528	469	531	919	1,176	838	502	588	644
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	406	56	630	579	652	1,056	1,302	923	613	703	772
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.05	2.68	4.06	3.60	7.58	8.90	10.29	5.50	6.53	7.27	10.84
Price to Tangible Book Value (P/TBV)	3.25	3.25	4.89	5.40	11.95	11.88	12.80	6.76	7.95	8.51	13.63
Price to Revenue (P/Rev)	2.45	2.79	3.71	2.61	4.89	6.29	7.12	4.27	6.17	7.26	9.50
Price to Earnings (P/E)	19.47	0.00	30.76	12.13	23.99	25.04	25.99	18.83	36.78	37.77	54.69
Dividend Yield	1.23%	0.99%	0.69%	1.18%	0.54%	0.34%	0.25%	0.51%	0.41%	0.38%	0.25%
Earnings Yield	5.13%	0.00%	3.25%	8.25%	4.17%	3.99%	3.85%	5.31%	2.72%	2.65%	1.83%
Enterprise Value to Invested Capital (EV/IC)	3.11	6.38	14.56	6.40	12.21	17.34	21.31	8.37	9.96	12.03	14.68
Enterprise Value to Revenue (EV/Rev)	1.85	2.07	3.00	2.23	4.62	5.93	6.75	3.97	5.82	6.83	9.25
Enterprise Value to EBITDA (EV/EBITDA)	7.45	64.81	10.19	8.10	16.27	17.51	19.19	13.57	25.40	27.40	38.21
Enterprise Value to EBIT (EV/EBIT)	12.22	0.00	12.14	9.99	19.96	20.12	21.24	14.95	31.01	32.77	45.80
Enterprise Value to NOPAT (EV/NOPAT)	15.28	0.00	24.85	10.25	21.53	22.89	23.80	17.68	36.39	35.96	51.68
Enterprise Value to Operating Cash Flow (EV/OCF)	7.16	7.99	10.24	9.83	18.32	21.28	22.74	21.67	26.60	28.66	43.76
Enterprise Value to Free Cash Flow (EV/FCFF)	482.24	10.12	16.56	28.36	29.72	30.34	26.47	32.59	43.16	38.68	182.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.19	0.20	0.27	0.27	0.19	0.04	0.02	0.00	0.00	0.07
Long-Term Debt to Equity	0.00	0.19	0.19	0.25	0.27	0.17	0.03	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.59	-0.73	-0.66	-0.47	-0.48	-0.53	-0.47	-0.39	-0.41	-0.36
Leverage Ratio	1.26	1.40	1.55	1.67	1.83	1.74	1.56	1.46	1.40	1.35	1.41
Compound Leverage Factor	1.28	1.27	1.54	1.67	1.81	1.71	1.54	1.46	1.47	1.39	1.42
Debt to Total Capital	0.78%	16.21%	16.66%	21.41%	21.43%	15.65%	4.06%	2.00%	0.00%	0.00%	6.68%
Short-Term Debt to Total Capital	0.78%	0.05%	1.05%	1.80%	0.48%	1.27%	0.72%	2.00%	0.00%	0.00%	6.68%
Long-Term Debt to Total Capital	0.00%	16.16%	15.61%	19.62%	20.95%	14.38%	3.34%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.14%	0.06%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.22%	83.79%	83.34%	78.59%	78.57%	84.21%	95.89%	98.00%	100.00%	100.00%	93.32%
Debt to EBITDA	0.04	6.31	0.62	0.72	0.62	0.39	0.08	0.05	0.00	0.00	0.26
Net Debt to EBITDA	-2.44	-22.45	-2.40	-1.36	-0.94	-1.08	-1.07	-1.03	0.00	0.00	-1.02
Long-Term Debt to EBITDA	0.00	6.29	0.58	0.66	0.61	0.36	0.07	0.00	0.00	0.00	0.00
Debt to NOPAT	0.08	-8.02	1.51	0.91	0.82	0.51	0.10	0.07	0.00	0.00	0.35
Net Debt to NOPAT	-5.01	28.56	-5.86	-1.73	-1.24	-1.42	-1.33	-1.35	0.00	0.00	-1.38
Long-Term Debt to NOPAT	0.00	-8.00	1.42	0.83	0.80	0.47	0.09	0.00	0.00	0.00	0.00
Altman Z-Score	5.78	4.37	6.19	4.60	6.96	10.57	15.52	10.20	12.35	15.86	14.86
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	0.11%	0.03%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.38	4.36	5.00	3.64	3.08	3.45	3.20	3.03	3.28	2.91	1.75
Quick Ratio	2.56	3.68	4.51	2.96	2.36	2.76	2.38	1.86	1.88	1.71	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	6.28	359	387	165	357	610	944	384	361	498	162
Operating Cash Flow to CapEx	470.72%	533.82%	594.54%	416.93%	429.84%	469.75%	829.13%	361.57%	366.59%	92.06%	270.28%
Free Cash Flow to Firm to Interest Expense	3.35	98.78	17.88	7.59	16.05	25.21	52.96	103.30	94.78	138.86	23.63
Operating Cash Flow to Interest Expense	225.52	125.16	28.92	21.90	26.04	35.93	61.64	155.40	153.77	187.39	98.51
Operating Cash Flow Less CapEx to Interest Expense	177.61	101.71	24.06	16.64	19.98	28.28	54.20	112.42	111.82	-16.16	62.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.64	0.66	0.73	0.72	0.84	0.97	0.99	0.86	0.77	0.78	0.81
Accounts Receivable Turnover	9.05	8.69	9.19	7.45	7.02	7.26	7.06	6.06	5.86	6.31	5.07
Inventory Turnover	5.60	5.49	7.52	6.74	5.45	6.38	6.43	4.53	3.59	3.85	3.93
Fixed Asset Turnover	5.44	6.65	8.18	7.66	7.65	8.73	9.47	7.83	6.19	5.91	5.96
Accounts Payable Turnover	10.33	8.47	10.07	9.41	8.40	10.26	10.43	8.80	7.13	7.44	6.60
Days Sales Outstanding (DSO)	40.33	42.03	39.74	49.00	51.98	50.27	51.66	60.27	62.28	57.83	71.99
Days Inventory Outstanding (DIO)	65.22	66.50	48.56	54.12	66.92	57.23	56.78	80.54	101.69	94.83	92.85
Days Payable Outstanding (DPO)	35.32	43.11	36.25	38.78	43.43	35.56	34.98	41.50	51.22	49.08	55.32
Cash Conversion Cycle (CCC)	70.23	65.41	52.05	64.34	75.47	71.94	73.46	99.31	112.75	103.58	109.52
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	973	570	440	733	868	1,067	1,172	1,496	1,563	1,601	2,010
Invested Capital Turnover	1.87	2.27	4.23	3.58	2.87	3.23	3.31	2.36	1.75	1.78	1.77
Increase / (Decrease) in Invested Capital	192	-403	-129	292	136	198	106	324	67	38	409
Enterprise Value (EV)	3,028	3,635	6,414	4,688	10,601	18,495	24,979	12,521	15,568	19,267	29,515
Market Capitalization	4,021	4,894	7,927	5,478	11,212	19,636	26,369	13,476	16,505	20,486	30,300
Book Value per Share	$9.57	$9.09	$9.96	$8.49	$8.83	$13.29	$15.72	$15.74	$16.52	$17.31	$17.85
Tangible Book Value per Share	$6.02	$7.48	$8.27	$5.66	$5.60	$9.95	$12.64	$12.81	$13.57	$14.79	$14.20
Total Capital	1,981	2,182	2,344	1,937	1,884	2,621	2,672	2,501	2,526	2,819	2,996
Total Debt	16	354	390	415	404	410	108	50	0.00	0.00	200
Total Long-Term Debt	0.00	353	366	380	395	377	89	0.00	0.00	0.00	0.00
Net Debt	-993	-1,259	-1,513	-790	-612	-1,144	-1,392	-955	-937	-1,218	-785
Capital Expenditures (CapEx)	90	85	105	114	135	185	132	160	160	730	250
Debt-free, Cash-free Net Working Capital (DFCFNWC)	160	73	63	174	218	312	424	667	682	592	712
Debt-free Net Working Capital (DFNWC)	903	1,252	1,840	1,291	1,129	1,748	1,790	1,562	1,502	1,192	1,034
Net Working Capital (NWC)	887	1,251	1,816	1,256	1,120	1,715	1,771	1,512	1,502	1,192	834
Net Nonoperating Expense (NNE)	-8.28	-0.66	0.46	5.79	25	24	35	-7.19	-21	-6.59	17
Net Nonoperating Obligations (NNO)	-993	-1,259	-1,513	-790	-612	-1,144	-1,392	-955	-963	-1,218	-785
Total Depreciation and Amortization (D&A)	159	117	101	110	121	137	125	85	111	115	128
Debt-free, Cash-free Net Working Capital to Revenue	9.77%	4.18%	2.93%	8.29%	9.49%	9.98%	11.45%	21.15%	25.50%	21.00%	22.32%
Debt-free Net Working Capital to Revenue	55.05%	71.42%	86.14%	61.46%	49.19%	56.00%	48.35%	49.50%	56.13%	42.26%	32.42%
Net Working Capital to Revenue	54.11%	71.36%	84.99%	59.80%	48.80%	54.93%	47.83%	47.91%	56.13%	42.26%	26.15%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.98	($0.21)	$1.30	$2.41	$2.74	$4.72	$6.15	$4.52	$2.91	$3.41	$3.48
Adjusted Weighted Average Basic Shares Outstanding	211.54M	202.58M	198.07M	187.67M	170.43M	166.12M	164.96M	158.43M	154.31M	159.08M	159.12M
Adjusted Diluted Earnings per Share	$0.97	($0.21)	$1.28	$2.35	$2.60	$4.28	$5.53	$4.22	$2.73	$3.32	$3.47
Adjusted Weighted Average Diluted Shares Outstanding	213.32M	202.58M	201.64M	192.61M	179.46M	183.04M	183.63M	169.73M	164.30M	163.31M	159.72M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$2.74	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	204.34M	200.30M	195.42M	173.63M	166.78M	166.69M	162.42M	156.05M	153.08M	161.72M	156.56M
Normalized Net Operating Profit after Tax (NOPAT)	202	208	374	472	480	796	1,057	723	446	550	605
Normalized NOPAT Margin	12.34%	11.87%	17.52%	22.48%	20.91%	25.52%	28.56%	22.91%	16.66%	19.50%	18.97%
Pre Tax Income Margin	15.44%	-3.14%	24.54%	22.27%	22.91%	28.87%	31.35%	26.64%	19.64%	21.60%	20.48%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	132.08	-16.69	24.39	21.54	23.89	38.01	66.00	225.26	131.90	163.90	94.13
NOPAT to Interest Expense	105.65	-12.12	11.92	21.01	22.15	33.41	58.89	190.46	112.41	149.37	83.43
EBIT Less CapEx to Interest Expense	84.17	-40.14	19.52	16.29	17.84	30.36	58.57	182.28	89.96	-39.66	57.68
NOPAT Less CapEx to Interest Expense	57.74	-35.57	7.05	15.76	16.09	25.76	51.45	147.48	70.46	-54.19	46.98
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	24.56%	-111.97%	21.52%	14.90%	13.11%	8.48%	6.50%	9.74%	15.13%	14.09%	13.77%
Augmented Payout Ratio	169.83%	-448.98%	99.25%	197.18%	120.07%	19.76%	65.64%	114.86%	103.65%	50.70%	140.49%

This table displays calculated financial ratios and metrics derived from Teradyne's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/1/2023	12/31/2023	3/31/2024	6/30/2024	9/29/2024	12/31/2024	3/30/2025	6/29/2025	9/28/2025	12/31/2025	3/29/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	156,555,950.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	156,555,950.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2.55
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.91%	-8.37%	-2.87%	6.64%	4.77%	12.27%	14.31%	-10.70%	4.33%	43.89%	87.04%
EBITDA Growth	-34.45%	-18.11%	-22.09%	46.83%	11.26%	12.74%	54.61%	-49.05%	-4.60%	76.90%	244.07%
EBIT Growth	-38.68%	-31.68%	-29.22%	54.01%	11.81%	16.33%	74.66%	-56.58%	-5.49%	89.49%	306.48%
NOPAT Growth	-31.92%	-29.20%	-14.29%	53.55%	9.77%	42.49%	54.84%	-55.64%	-12.78%	77.78%	286.52%
Net Income Growth	-30.18%	-32.06%	-23.15%	55.16%	13.69%	24.94%	54.05%	-57.93%	-17.91%	75.87%	303.36%
EPS Growth	-29.09%	-30.77%	-20.00%	56.16%	14.10%	23.61%	52.50%	-57.02%	-15.73%	82.02%	314.75%
Operating Cash Flow Growth	-35.81%	35.65%	-62.36%	51.34%	-4.63%	13.58%	2,120.59%	-15.73%	-70.50%	-0.32%	64.02%
Free Cash Flow Firm Growth	-937.43%	120.89%	119.13%	456.40%	215.84%	199.01%	192.67%	-148.22%	-245.62%	-231.69%	-251.57%
Invested Capital Growth	14.85%	4.48%	2.12%	-1.94%	2.57%	2.41%	0.38%	11.15%	15.73%	25.57%	33.66%
Revenue Q/Q Growth	2.82%	-4.71%	-10.55%	21.68%	1.02%	2.11%	-8.93%	-4.94%	18.01%	40.84%	18.38%
EBITDA Q/Q Growth	0.12%	-4.08%	-41.25%	160.27%	-24.13%	-2.81%	-19.44%	-14.23%	42.07%	84.58%	52.99%
EBIT Q/Q Growth	-0.52%	-4.78%	-50.14%	226.07%	-27.78%	-0.93%	-25.14%	-18.94%	57.20%	98.63%	60.59%
NOPAT Q/Q Growth	9.91%	-18.58%	-34.21%	160.79%	-21.42%	5.69%	-28.51%	-25.29%	54.50%	115.43%	55.44%
Net Income Q/Q Growth	6.72%	-8.63%	-45.16%	190.16%	-21.81%	0.41%	-32.38%	-20.75%	52.55%	115.14%	55.08%
EPS Q/Q Growth	6.85%	-7.69%	-44.44%	185.00%	-21.93%	0.00%	-31.46%	-19.67%	53.06%	116.00%	56.17%
Operating Cash Flow Q/Q Growth	22.12%	42.69%	-97.07%	2,868.39%	-23.05%	69.94%	-42.79%	12.65%	-73.06%	474.19%	-5.86%
Free Cash Flow Firm Q/Q Growth	-43.29%	143.68%	-7.97%	518.83%	-53.43%	12.73%	-9.93%	-201.97%	-40.64%	-1.95%	-3.67%
Invested Capital Q/Q Growth	-0.62%	-4.93%	6.18%	-2.26%	3.95%	-5.07%	4.08%	8.22%	8.24%	3.00%	10.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.60%	56.60%	56.56%	58.34%	59.20%	59.41%	60.57%	57.23%	58.41%	57.20%	60.89%
EBITDA Margin	23.66%	23.81%	15.64%	33.45%	25.13%	23.91%	21.15%	19.09%	22.98%	30.11%	38.91%
Operating Margin	20.46%	18.54%	12.97%	28.82%	20.62%	20.40%	17.62%	13.92%	18.89%	27.06%	36.88%
EBIT Margin	19.66%	19.65%	10.95%	29.35%	20.98%	20.36%	16.73%	14.27%	19.01%	26.81%	36.37%
Profit (Net Income) Margin	18.21%	17.46%	10.70%	25.52%	19.75%	19.43%	14.42%	12.02%	15.54%	23.74%	31.10%
Tax Burden Percent	88.80%	83.73%	88.06%	84.90%	91.61%	92.68%	83.09%	81.16%	80.73%	88.83%	85.66%
Interest Burden Percent	104.27%	106.11%	110.97%	102.42%	102.76%	102.95%	103.73%	103.81%	101.29%	99.70%	99.84%
Effective Tax Rate	11.20%	16.27%	11.94%	15.10%	7.71%	3.43%	12.22%	12.70%	15.76%	10.07%	13.35%
Return on Invested Capital (ROIC)	32.33%	27.16%	18.48%	40.38%	31.29%	35.11%	27.02%	20.06%	25.01%	43.00%	62.16%
ROIC Less NNEP Spread (ROIC-NNEP)	32.30%	25.80%	18.98%	39.57%	30.76%	35.30%	27.72%	20.14%	25.30%	43.65%	63.23%
Return on Net Nonoperating Assets (RNNOA)	-11.14%	-9.94%	-6.53%	-14.47%	-11.59%	-14.40%	-10.50%	-7.75%	-8.92%	-15.57%	-21.79%
Return on Equity (ROE)	21.19%	17.21%	11.95%	25.92%	19.70%	20.71%	16.52%	12.31%	16.09%	27.43%	40.37%
Cash Return on Invested Capital (CROIC)	16.82%	23.58%	23.24%	31.16%	26.96%	31.48%	34.09%	17.11%	10.48%	8.96%	16.14%
Operating Return on Assets (OROA)	16.09%	15.05%	8.57%	22.59%	16.09%	15.96%	13.67%	10.92%	14.06%	21.67%	33.84%
Return on Assets (ROA)	14.90%	13.37%	8.38%	19.64%	15.15%	15.23%	11.78%	9.20%	11.49%	19.19%	28.94%
Return on Common Equity (ROCE)	21.19%	17.21%	11.95%	25.92%	19.70%	20.71%	16.52%	12.31%	16.09%	27.43%	40.37%
Return on Equity Simple (ROE_SIMPLE)	20.64%	0.00%	16.79%	18.15%	17.68%	0.00%	20.63%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	128	104	68	179	140	148	106	79	122	264	410
NOPAT Margin	18.17%	15.52%	11.42%	24.47%	19.03%	19.70%	15.47%	12.15%	15.91%	24.34%	31.96%
Net Nonoperating Expense Percent (NNEP)	0.03%	1.35%	-0.50%	0.81%	0.53%	-0.19%	-0.70%	-0.08%	-0.29%	-0.65%	-1.07%
Return On Investment Capital (ROIC_SIMPLE)	-	4.12%	-	-	-	5.26%	3.79%	2.79%	4.20%	8.80%	13.04%
Cost of Revenue to Revenue	43.40%	43.40%	43.44%	41.66%	40.80%	40.59%	39.43%	42.77%	41.59%	42.80%	39.11%
SG&A Expenses to Revenue	19.66%	21.23%	24.87%	21.16%	21.38%	20.69%	22.93%	24.21%	21.99%	15.20%	13.00%
R&D to Revenue	14.84%	15.24%	17.21%	15.32%	15.93%	17.05%	17.24%	18.16%	16.22%	13.22%	10.57%
Operating Expenses to Revenue	36.14%	38.06%	43.60%	29.52%	38.58%	39.01%	42.95%	43.31%	39.52%	30.14%	24.01%
Earnings before Interest and Taxes (EBIT)	138	132	66	214	155	153	115	93	146	290	466
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	167	160	94	244	185	180	145	124	177	326	499
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.31	6.53	6.74	8.48	7.57	7.27	4.79	5.11	7.92	10.84	14.72
Price to Tangible Book Value (P/TBV)	7.70	7.95	8.13	10.06	8.92	8.51	5.65	6.42	10.04	13.63	17.93
Price to Revenue (P/Rev)	5.63	6.17	6.48	8.56	8.03	7.26	4.61	5.13	7.53	9.50	12.22
Price to Earnings (P/E)	30.57	36.78	40.13	46.71	42.81	37.77	23.20	30.89	48.58	54.69	54.19
Dividend Yield	0.44%	0.41%	0.40%	0.31%	0.35%	0.38%	0.58%	0.53%	0.35%	0.25%	0.17%
Earnings Yield	3.27%	2.72%	2.49%	2.14%	2.34%	2.65%	4.31%	3.24%	2.06%	1.83%	1.85%
Enterprise Value to Invested Capital (EV/IC)	8.89	9.96	9.86	13.59	12.31	12.03	7.36	7.46	10.64	14.68	20.37
Enterprise Value to Revenue (EV/Rev)	5.34	5.82	6.16	8.15	7.58	6.83	4.22	4.76	7.26	9.25	11.98
Enterprise Value to EBITDA (EV/EBITDA)	21.68	25.40	27.91	33.19	30.39	27.40	16.24	21.21	33.15	38.21	40.27
Enterprise Value to EBIT (EV/EBIT)	25.95	31.01	34.46	40.07	36.64	32.77	19.24	26.10	40.92	45.80	45.54
Enterprise Value to NOPAT (EV/NOPAT)	31.00	36.39	39.32	46.07	42.26	35.96	21.38	28.40	45.52	51.68	51.84
Enterprise Value to Operating Cash Flow (EV/OCF)	28.11	26.60	28.55	34.09	32.51	28.66	14.83	16.98	30.74	43.76	58.31
Enterprise Value to Free Cash Flow (EV/FCFF)	56.47	43.16	42.86	43.17	46.23	38.68	21.62	45.92	108.84	182.47	144.41
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.07	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.34	-0.39	-0.34	-0.37	-0.38	-0.41	-0.38	-0.38	-0.35	-0.36	-0.34
Leverage Ratio	1.42	1.40	1.36	1.36	1.34	1.35	1.33	1.33	1.38	1.41	1.37
Compound Leverage Factor	1.49	1.49	1.51	1.39	1.37	1.39	1.38	1.38	1.39	1.40	1.37
Debt to Total Capital	0.95%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.86%	6.68%	0.00%
Short-Term Debt to Total Capital	0.95%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.86%	6.68%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.05%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	93.14%	93.32%	100.00%
Debt to EBITDA	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.32	0.26	0.00
Net Debt to EBITDA	-1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.22	-1.02	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.35	0.00
Net Debt to NOPAT	-1.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.68	-1.38	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	11.69	12.00	13.80	17.07	16.83	15.47	10.42	10.84	11.68	14.58	23.39
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.28	3.28	3.73	2.80	3.09	2.91	2.70	2.35	1.76	1.75	2.15
Quick Ratio	1.83	1.88	2.12	1.49	1.74	1.71	1.49	1.19	0.90	0.99	1.34
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-85	37	34	211	98	111	100	-102	-143	-146	-151
Operating Cash Flow to CapEx	503.83%	561.12%	16.53%	37.94%	306.50%	452.92%	241.13%	345.09%	73.38%	447.84%	409.57%
Free Cash Flow to Firm to Interest Expense	-87.98	45.63	51.52	137.73	121.47	188.17	125.36	-126.24	-109.18	-37.01	-47.94
Operating Cash Flow to Interest Expense	181.05	306.76	11.01	141.22	205.78	480.54	203.32	226.20	37.47	71.54	84.14
Operating Cash Flow Less CapEx to Interest Expense	145.11	252.09	-55.59	-231.00	138.64	374.44	119.00	160.65	-13.59	55.56	63.60
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.77	0.78	0.77	0.77	0.78	0.82	0.76	0.74	0.81	0.93
Accounts Receivable Turnover	5.55	5.86	6.03	5.61	5.82	6.31	6.55	6.26	5.30	5.07	4.83
Inventory Turnover	3.66	3.59	3.42	3.65	3.73	3.85	3.58	3.62	3.54	3.93	4.42
Fixed Asset Turnover	6.43	6.19	5.98	5.95	5.90	5.91	5.82	5.48	5.39	5.96	6.72
Accounts Payable Turnover	6.74	7.13	7.69	7.40	6.91	7.44	6.93	6.94	6.08	6.60	5.88
Days Sales Outstanding (DSO)	65.75	62.28	60.52	65.03	62.68	57.83	55.69	58.30	68.81	71.99	75.56
Days Inventory Outstanding (DIO)	99.66	101.69	106.76	99.98	97.84	94.83	101.90	100.96	103.18	92.85	82.60
Days Payable Outstanding (DPO)	54.14	51.22	47.47	49.35	52.80	49.08	52.69	52.57	60.02	55.32	62.05
Cash Conversion Cycle (CCC)	111.27	112.75	119.81	115.66	107.72	103.58	104.90	106.70	111.97	109.52	96.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,644	1,563	1,660	1,622	1,687	1,601	1,666	1,803	1,952	2,010	2,227
Invested Capital Turnover	1.78	1.75	1.62	1.65	1.64	1.78	1.75	1.65	1.57	1.77	1.95
Increase / (Decrease) in Invested Capital	213	67	34	-32	42	38	6.38	181	265	409	561
Enterprise Value (EV)	14,611	15,568	16,364	22,041	20,754	19,267	12,256	13,460	20,759	29,515	45,363
Market Capitalization	15,408	16,505	17,234	23,150	21,970	20,486	13,387	14,494	21,524	30,300	46,280
Book Value per Share	$15.85	$16.52	$16.71	$17.49	$17.79	$17.31	$17.30	$17.69	$17.08	$17.85	$20.08
Tangible Book Value per Share	$12.99	$13.57	$13.85	$14.73	$15.09	$14.79	$14.66	$14.08	$13.47	$14.20	$16.48
Total Capital	2,465	2,526	2,558	2,731	2,903	2,819	2,797	2,837	2,917	2,996	3,144
Total Debt	24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	200	200	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-797	-937	-871	-1,108	-1,216	-1,218	-1,131	-1,034	-765	-785	-917
Capital Expenditures (CapEx)	35	44	44	569	54	62	67	53	67	63	65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	766	682	762	669	692	592	599	540	657	712	915
Debt-free Net Working Capital (DFNWC)	1,482	1,502	1,511	1,130	1,244	1,192	1,107	908	955	1,034	1,161
Net Working Capital (NWC)	1,459	1,502	1,511	1,130	1,244	1,192	1,107	908	755	834	1,161
Net Nonoperating Expense (NNE)	-0.27	-13	4.29	-7.67	-5.31	2.07	7.15	0.85	2.84	6.47	11
Net Nonoperating Obligations (NNO)	-797	-963	-898	-1,108	-1,216	-1,218	-1,131	-1,034	-765	-785	-917
Total Depreciation and Amortization (D&A)	28	28	28	30	31	27	30	31	31	36	33
Debt-free, Cash-free Net Working Capital to Revenue	27.97%	25.50%	28.67%	24.76%	25.29%	21.00%	20.61%	19.11%	22.99%	22.32%	24.17%
Debt-free Net Working Capital to Revenue	54.14%	56.13%	56.84%	41.79%	45.44%	42.26%	38.08%	32.12%	33.40%	32.42%	30.66%
Net Working Capital to Revenue	53.29%	56.13%	56.84%	41.79%	45.44%	42.26%	38.08%	32.12%	26.41%	26.15%	30.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.83	$0.76	$0.42	$1.18	$0.89	$0.92	$0.61	$0.49	$0.75	$1.63	$2.55
Adjusted Weighted Average Basic Shares Outstanding	153.76M	154.31M	153.05M	157.80M	163.00M	159.08M	161.50M	159.97M	158.60M	159.12M	156.41M
Adjusted Diluted Earnings per Share	$0.78	$0.72	$0.40	$1.14	$0.89	$0.89	$0.61	$0.49	$0.75	$1.62	$2.53
Adjusted Weighted Average Diluted Shares Outstanding	164.05M	164.30M	162.35M	163.47M	164.25M	163.31M	162.00M	160.14M	159.10M	159.72M	157.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	152.88M	153.08M	156.11M	163.18M	162.86M	161.72M	160.42M	159.07M	156.61M	156.56M	156.54M
Normalized Net Operating Profit after Tax (NOPAT)	134	109	72	180	145	153	119	81	128	277	413
Normalized NOPAT Margin	19.03%	16.27%	12.07%	24.70%	19.61%	20.28%	17.32%	12.47%	16.63%	25.59%	32.19%
Pre Tax Income Margin	20.50%	20.85%	12.15%	30.06%	21.56%	20.96%	17.36%	14.81%	19.25%	26.73%	36.31%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	143.69	162.46	99.39	140.01	191.48	260.67	144.33	115.54	111.70	73.77	148.02
NOPAT to Interest Expense	132.75	128.35	103.61	116.73	173.69	252.25	133.39	98.41	93.51	66.98	130.08
EBIT Less CapEx to Interest Expense	107.75	107.79	32.79	-232.21	124.34	154.57	60.01	50.00	60.64	57.80	127.47
NOPAT Less CapEx to Interest Expense	96.82	73.68	37.01	-255.49	106.55	146.15	49.07	32.87	42.44	51.00	109.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	13.53%	15.13%	16.09%	14.34%	14.37%	14.09%	13.42%	16.55%	17.39%	13.77%	9.05%
Augmented Payout Ratio	82.70%	103.65%	92.02%	54.63%	34.99%	50.70%	71.29%	111.00%	166.84%	140.49%	73.46%

Financials Breakdown Chart

Key Financial Trends

Teradyne (TER) continues to show a rebound in 2025, with a standout Q4 that features strong revenue growth, expanding profitability, and solid operating cash flow. Below are the most noteworthy trends drawn from the last four years of quarterly statements. Items are grouped to highlight positives first, then neutral points, then negatives.

Strong Q4 2025 revenue growth vs. year-ago: Operating revenue rose to 1,083,337,000 from 752,884,000 in Q4 2024, a year-over-year gain of roughly 44%.
Significant net income growth in Q4 2025: Net income (continuing operations) was 257,221,000, up from 146,253,000 in Q4 2024; Basic EPS increased to 1.63 from 0.75.
Operating income expanded in Q4 2025: Total operating income reached 293,202,000 vs. 157,797,000 in Q4 2024, indicating improving profitability.
Robust quarterly cash flow from operations: Net cash from continuing operating activities was 281,639,000 in Q4 2025, broadly in line with Q4 2024 (282,557,000), signaling solid cash generation.
Capital returns via share buybacks: Teradyne executed notable share repurchases in late 2025 (e.g., 183,437,000 in cash outflow), which can support per-share metrics and ROE over time.
Balanced liquidity with limited long-term debt: The balance sheet shows no long-term debt outstanding in recent periods and a strong equity base (Total Common Equity around 2.7B in mid-2025), supporting liquidity and financial flexibility.
Gross margin modestly declined year-over-year in Q4: Gross margin was about 57.1% in Q4 2025 vs. roughly 59.4% in Q4 2024, indicating a slight compression as revenue mix or costs shift.
Capex remains at a steady, moderate level: Purchase of PPE typically in the 60–70M range per quarter (example: 62.9M in Q4 2025), suggesting ongoing but controlled investment in capacity.
Net financing cash outflows remained substantial in Q4 2025: Net cash from financing activities was negative by 200,840,000, driven by share repurchases, debt activity, and dividends, which reduced cash despite strong operating cash flow.

05/05/26 05:27 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Teradyne's Financials

When does Teradyne's financial year end?

According to the most recent income statement we have on file, Teradyne's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Teradyne's net income changed over the last 10 years?

Teradyne's net income appears to be on an upward trend, with a most recent value of $554.05 million in 2025, rising from $206.48 million in 2015. The previous period was $542.37 million in 2024. Find out what analysts predict for Teradyne in the coming months.

What is Teradyne's operating income?

Teradyne's total operating income in 2025 was $650.05 million, based on the following breakdown:

Total Gross Profit: $1.86 billion
Total Operating Expenses: $1.21 billion

How has Teradyne's revenue changed over the last 10 years?

Over the last 10 years, Teradyne's total revenue changed from $1.64 billion in 2015 to $3.19 billion in 2025, a change of 94.6%.

How much debt does Teradyne have?

Teradyne's total liabilities were at $1.39 billion at the end of 2025, a 56.0% increase from 2024, and a 138.1% increase since 2015.

How much cash does Teradyne have?

In the past 10 years, Teradyne's cash and equivalents has ranged from $264.71 million in 2015 to $1.12 billion in 2021, and is currently $293.75 million as of their latest financial filing in 2025.

How has Teradyne's book value per share changed over the last 10 years?

Over the last 10 years, Teradyne's book value per share changed from 9.57 in 2015 to 17.85 in 2025, a change of 86.6%.

Related Companies

Financial statements for NASDAQ:TER last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teradyne (TER) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Teradyne's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Teradyne (TER) Financials

Annual Income Statements for Teradyne

Quarterly Income Statements for Teradyne

Annual Cash Flow Statements for Teradyne

Quarterly Cash Flow Statements for Teradyne

Annual Balance Sheets for Teradyne

Quarterly Balance Sheets for Teradyne

Annual Metrics And Ratios for Teradyne

Quarterly Metrics And Ratios for Teradyne

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Teradyne's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools